hagens.jpg
4-DAY DEADLINE ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Myriad Genetics (MYGN) Investors Who Suffered Significant Losses to Contact Its Attorneys, Application Deadline is Approaching
November 22, 2019 18:01 ET | Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Nov. 22, 2019 (GLOBE NEWSWIRE) -- Hagens Berman urges Myriad Genetics, Inc. (NASDAQ: MYGN) investors who have suffered losses in excess of $50,000 to submit their losses now or...
hagens.jpg
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds Myriad Genetics (MYGN) Investors of Securities Class Action: Investors Who Suffered Significant Losses are Encouraged to Contact the Firm
October 29, 2019 20:04 ET | Hagens Berman Sobol Shapiro LLP
Class-action law firm urges MYGN investors who have suffered losses of $50K+ to submit your loss now to learn if they qualify to recover their investment losses. SAN FRANCISCO, Oct. 29, 2019 (GLOBE...
HAGENS-BERMAN-securities-press-release.jpg
MYGN SHAREHOLDER REMINDER: Hagens Berman Reminds Myriad Genetics (MYGN) Investors of Securities Fraud Lawsuit, Encourages Investors Who Lost $50,000+ to Contact the Firm
October 16, 2019 20:04 ET | Hagens Berman Sobol Shapiro LLP
Class-action law firm urges MYGN investors who have suffered losses of $50K+ to submit your loss now to learn if they qualify to recover their investment losses. SAN FRANCISCO, Oct. 16, 2019 (GLOBE...
HAGENS-BERMAN-securities-press-release.jpg
MYGN CLASS ACTION REMINDER: Hagens Berman Reminds Investors in Myriad Genetics (MYGN) of Securities Fraud Lawsuit
October 01, 2019 20:04 ET | Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Hagens Berman reminds investors in Myriad Genetics, Inc. (NASDAQ: MYGN) of the pending securities class action and urges MYGN investors who have...
HAGENS-BERMAN-securities-press-release.jpg
MYGN INVESTIGATION REMINDER: Hagens Berman Reminds Myriad Genetics (MYGN) Investors of the Firm’s Ongoing Investigation of Possible Disclosure Violations
September 23, 2019 20:02 ET | Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Sept. 23, 2019 (GLOBE NEWSWIRE) -- Hagens Berman reminds investors in Myriad Genetics, Inc. (NASDAQ: MYGN) of the firm’s investigation of possible disclosure violations. RELEVANT...
HAGENS-BERMAN-securities-press-release.jpg
MYGN Loss Alert: Hagens Berman Reminds Myriad Genetics (MYGN) Investors of Ongoing Investigation for Possible Disclosure Violations
September 17, 2019 20:06 ET | Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Sept. 17, 2019 (GLOBE NEWSWIRE) -- Hagens Berman reminds investors in Myriad Genetics, Inc. (NASDAQ: MYGN) of the firm’s investigation of possible disclosure violations. RELEVANT...
HB Press Release Logo.jpg
MYGN INVESTIGATION REMINDER: Hagens Berman Investigating Myriad Genetics (MYGN) For Possible Disclosure Violations
September 03, 2019 20:12 ET | Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Hagens Berman reminds investors in Myriad Genetics, Inc. (NASDAQ: MYGN) of the firm’s investigation of possible disclosure violations concerning its...
HB Press Release Logo.jpg
MYGN Loss Alert: Hagens Berman Investigating Myriad Genetics (MYGN) For Possible Disclosure Violations
August 21, 2019 20:13 ET | Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Hagens Berman reminds investors in Myriad Genetics, Inc. (NASDAQ: MYGN) of the firm’s investigation of possible disclosure violations concerning its...